This site uses no trackers, cookies, and no data is collected from visitors of this site.
Trypt.am is a shortening for the word *tryptamine*.
info (at) entheos (dot) org (dot) nz
To see complete record on clinicaltrials.gov, please visit this link
Organisation Name: Takeda
Overal Status: Completed
Start Date: February 11, 2019
Last Update: July 2, 2020
Lead Sponsor: Millennium Pharmaceuticals, Inc.
Brief Summary: The primary purpose of this study is to determine whether TAK-653, in comparison to placebo, increases CNS excitability, assessed with TMS-evoked motor-evoked potential (MEP) in healthy participants.Conditions: